All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
USO / United States Oil Fund, LP - Limited Partnership Call
|
|
|
|
|
|
|
|
Arrowhead Research Corp
/ (042797209) |
|
|
|
|
|
|
|
AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
NVRO / Nevro Corp. Put
|
|
|
|
|
|
|
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
SSRG / Symmetry Surgical Inc.
|
|
|
|
|
|
|
|
IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
LENSF / Presbia PLC
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VIVO / Meridian Bioscience Inc. Call
|
|
|
|
|
|
|
|
CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
VBIV / VBI Vaccines Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BRK.B / Berkshire Hathaway Inc.
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company Call
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|